Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-life data on the impact of successful downstaging in patients with hepatocellular carcinoma: A Dutch Multicenter Study.
Broekhoven AGC, Fiocco M, Sprengers D, Takkenberg RB, van Meer S, van Erpecum KJ, Ramsoekh D, Verspaget HW, Burgmans MC, Osanto S, Baranski AG, van Hoek B, Coenraad MJ. Broekhoven AGC, et al. Among authors: burgmans mc. Eur J Intern Med. 2022 Mar;97:56-61. doi: 10.1016/j.ejim.2021.12.009. Epub 2021 Dec 21. Eur J Intern Med. 2022. PMID: 34952770 Free article.
CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.
Karkampouna S, van der Helm D, Gray PC, Chen L, Klima I, Grosjean J, Burgmans MC, Farina-Sarasqueta A, Snaar-Jagalska EB, Stroka DM, Terracciano L, van Hoek B, Schaapherder AF, Osanto S, Thalmann GN, Verspaget HW, Coenraad MJ, Kruithof-de Julio M. Karkampouna S, et al. Among authors: burgmans mc. J Pathol. 2018 Jul;245(3):297-310. doi: 10.1002/path.5083. Epub 2018 May 9. J Pathol. 2018. PMID: 29604056
The role of proportionate kinetic growth rate fraction in future remnant liver function over volume determined by 99mTc-Mebrofenin hepatobiliary scintigraphy including SPECT and computed tomography in the risk prediction of postoperative mortality in ALPPS.
Lam HD, van der Pas SL, Baranski A, van Hoek B, Burgmans MC, Bennink RJ, de Geus-Oei LF. Lam HD, et al. Among authors: burgmans mc. Surgery. 2019 Jun;165(6):1244-1245. doi: 10.1016/j.surg.2018.10.020. Epub 2018 Nov 19. Surgery. 2019. PMID: 30467041 No abstract available.
Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems' Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial.
Meijer TS, Burgmans MC, Fiocco M, de Geus-Oei LF, Kapiteijn E, de Leede EM, Martini CH, van der Meer RW, Tijl FGJ, Vahrmeijer AL. Meijer TS, et al. Among authors: burgmans mc. Cardiovasc Intervent Radiol. 2019 Jun;42(6):841-852. doi: 10.1007/s00270-019-02177-x. Epub 2019 Feb 14. Cardiovasc Intervent Radiol. 2019. PMID: 30767147 Free PMC article. Clinical Trial.
Quantitative Volumetric Assessment of Ablative Margins in Hepatocellular Carcinoma: Predicting Local Tumor Progression Using Nonrigid Registration Software.
Hendriks P, Noortman WA, Baetens TR, van Erkel AR, van Rijswijk CSP, van der Meer RW, Coenraad MJ, de Geus-Oei LF, Slump CH, Burgmans MC. Hendriks P, et al. Among authors: burgmans mc. J Oncol. 2019 Sep 19;2019:4049287. doi: 10.1155/2019/4049287. eCollection 2019. J Oncol. 2019. PMID: 31641353 Free PMC article.
Trends in incidence, diagnosis, treatment and survival of hepatocellular carcinoma in a low-incidence country: Data from the Netherlands in the period 2009-2016.
Reinders MTM, van Meer S, Burgmans MC, de Jong KP, Klümpen HJ, de Man RA, Ramsoekh DS, Sprengers D, Tjwa ETTL, de Vos-Geelen J, van Erpecum KJ, van der Geest LGM; Dutch Hepatocellular & Cholangiocarcinoma Group (DHCG). Reinders MTM, et al. Among authors: burgmans mc. Eur J Cancer. 2020 Sep;137:214-223. doi: 10.1016/j.ejca.2020.07.008. Epub 2020 Aug 13. Eur J Cancer. 2020. PMID: 32799035
79 results